Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer-BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
This report contains market size and forecasts of Liposomal and Lipid Nanoparticle Drug Delivery Systems in Global, including the following market information:
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liposomal and Lipid Nanoparticle Drug Delivery Systems market was valued at 4704.1 million in 2021 and is projected to reach US$ 8918.9 million by 2028, at a CAGR of 9.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liposomal and Lipid Nanoparticle Drug Delivery Systems include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma and Pacira, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomal and Lipid Nanoparticle Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
- Liposomes Drugs
- Lipid Nanoparticle Drugs
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Retail Pharmacy
- Other
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal and Lipid Nanoparticle Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liposomal and Lipid Nanoparticle Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Sun Pharmaceutical
- CSPC
- Kinyond
- Teva
- Fudan-Zhangjiang
- Zydus Cadila
- TTY Biopharma
- Pacira
- Luye Pharma
- Leadiant Biosciences
- Ipsen
- Sayre Therapeutics
- Jazz
- Alnylam
- Bausch Health
- Acrotech Biopharma
- Takeda
- Chiesi Farmaceutici
- Gilead Sciences
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Overall Market Size
2.1 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomal and Lipid Nanoparticle Drug Delivery Systems Players in Global Market
3.2 Top Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Liposomes Drugs
4.1.3 Lipid Nanoparticle Drugs
4.2 By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028
6.3.2 US Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.3.3 Canada Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.3.4 Mexico Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028
6.4.2 Germany Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.3 France Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.4 U.K. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.5 Italy Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.6 Russia Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.7 Nordic Countries Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.4.8 Benelux Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028
6.5.2 China Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.5.3 Japan Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.5.4 South Korea Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.5.5 Southeast Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.5.6 India Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028
6.6.2 Brazil Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.6.3 Argentina Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028
6.7.2 Turkey Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.7.3 Israel Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.7.4 Saudi Arabia Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
6.7.5 UAE Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.1.4 Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Corporate Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.2.4 Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.2.5 Sun Pharmaceutical Key News
7.3 CSPC
7.3.1 CSPC Corporate Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.3.4 CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.3.5 CSPC Key News
7.4 Kinyond
7.4.1 Kinyond Corporate Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.4.4 Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.4.5 Kinyond Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.5.4 Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.5.5 Teva Key News
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Corporate Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.6.4 Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.6.5 Fudan-Zhangjiang Key News
7.7 Zydus Cadila
7.7.1 Zydus Cadila Corporate Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.7.4 Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.7.5 Zydus Cadila Key News
7.8 TTY Biopharma
7.8.1 TTY Biopharma Corporate Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.8.4 TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.8.5 TTY Biopharma Key News
7.9 Pacira
7.9.1 Pacira Corporate Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.9.4 Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.9.5 Pacira Key News
7.10 Luye Pharma
7.10.1 Luye Pharma Corporate Summary
7.10.2 Luye Pharma Business Overview
7.10.3 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.10.4 Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.10.5 Luye Pharma Key News
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Corporate Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.11.4 Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.11.5 Leadiant Biosciences Key News
7.12 Ipsen
7.12.1 Ipsen Corporate Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.12.4 Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.12.5 Ipsen Key News
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Corporate Summary
7.13.2 Sayre Therapeutics Business Overview
7.13.3 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.13.4 Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.13.5 Sayre Therapeutics Key News
7.14 Jazz
7.14.1 Jazz Corporate Summary
7.14.2 Jazz Business Overview
7.14.3 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.14.4 Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.14.5 Jazz Key News
7.15 Alnylam
7.15.1 Alnylam Corporate Summary
7.15.2 Alnylam Business Overview
7.15.3 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.15.4 Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.15.5 Alnylam Key News
7.16 Bausch Health
7.16.1 Bausch Health Corporate Summary
7.16.2 Bausch Health Business Overview
7.16.3 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.16.4 Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.16.5 Bausch Health Key News
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Corporate Summary
7.17.2 Acrotech Biopharma Business Overview
7.17.3 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.17.4 Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.17.5 Acrotech Biopharma Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.18.4 Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Corporate Summary
7.19.2 Chiesi Farmaceutici Business Overview
7.19.3 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.19.4 Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.19.5 Chiesi Farmaceutici Key News
7.20 Gilead Sciences
7.20.1 Gilead Sciences Corporate Summary
7.20.2 Gilead Sciences Business Overview
7.20.3 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Major Product Offerings
7.20.4 Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global Market (2017-2022)
7.20.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Drivers in Global Market
Table 3. Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Liposomal and Lipid Nanoparticle Drug Delivery Systems in Global Market
Table 5. Top Liposomal and Lipid Nanoparticle Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal and Lipid Nanoparticle Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 32. Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 33. Sun Pharmaceutical Corporate Summary
Table 34. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 35. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 36. CSPC Corporate Summary
Table 37. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 38. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 39. Kinyond Corporate Summary
Table 40. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 41. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 44. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 45. Fudan-Zhangjiang Corporate Summary
Table 46. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 47. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 48. Zydus Cadila Corporate Summary
Table 49. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 50. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 51. TTY Biopharma Corporate Summary
Table 52. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 53. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 54. Pacira Corporate Summary
Table 55. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 56. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 57. Luye Pharma Corporate Summary
Table 58. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 59. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 60. Leadiant Biosciences Corporate Summary
Table 61. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 62. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 63. Ipsen Corporate Summary
Table 64. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 65. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 66. Sayre Therapeutics Corporate Summary
Table 67. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 68. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 69. Jazz Corporate Summary
Table 70. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 71. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 72. Alnylam Corporate Summary
Table 73. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 74. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 75. Bausch Health Corporate Summary
Table 76. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 77. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 78. Acrotech Biopharma Corporate Summary
Table 79. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 80. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 81. Takeda Corporate Summary
Table 82. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 83. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 84. Chiesi Farmaceutici Corporate Summary
Table 85. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 86. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 87. Gilead Sciences Corporate Summary
Table 88. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Product Offerings
Table 89. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Liposomal and Lipid Nanoparticle Drug Delivery Systems Segment by Type in 2021
Figure 2. Liposomal and Lipid Nanoparticle Drug Delivery Systems Segment by Application in 2021
Figure 3. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue in 2021
Figure 8. By Type - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 12. US Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 16. Germany Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 17. France Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 24. China Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. India Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 30. Brazil Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 33. Turkey Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sun Pharmaceutical Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. CSPC Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kinyond Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fudan-Zhangjiang Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Zydus Cadila Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. TTY Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pacira Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Luye Pharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Leadiant Biosciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ipsen Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sayre Therapeutics Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Jazz Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Alnylam Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bausch Health Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Acrotech Biopharma Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Takeda Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Chiesi Farmaceutici Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Gilead Sciences Liposomal and Lipid Nanoparticle Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
